AFAP1-AS1 induces cisplatin resistance in non-small cell lung cancer through PI3K/AKT pathway

Cisplatin (DDP)-resistance in non-small cell lung carcinoma (NSCLC) severely influences the prognosis of affected patients. This study aims to uncover the potential role of AFAP1-AS1 in DDP-resistant NSCLC and the underlying mechanism. The expression level of AFAP1-AS1 in DDP-resistant NSCLC patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yang, Hu, Qiang, Wang, Xihui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924151/
https://www.ncbi.nlm.nih.gov/pubmed/31897216
http://dx.doi.org/10.3892/ol.2019.11175

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924151/
https://www.ncbi.nlm.nih.gov/pubmed/31897216
http://dx.doi.org/10.3892/ol.2019.11175

Ejemplares similares